A lot of advances have emerged from the Joint International Conference 2025 Innovation in Oncology organized by FGB with Prada Group supporting partner, by Fondazione Michelangelo and by European School of Oncology
fondazionebonadonna.org/en/from-new-...
#FondazioneGianniBonadonna #CancerResearch

The Godard Cinema of Fondazione Prada hosted today the opening press conference of the “Joint International Conference 2025”. The event is organized by FGB with the support of #PradaGroup #FondazioneMichelangelo and @ESOncology .
fondazionebonadonna.org/wp-content/u...
#CancerResearch #Oncology

Final overall survival data from SOLTI-1303-PATRICIA trial highlight the relevance of gene expression profiling in HER2+ breast cancer, validating the potential of non-chemotherapy approaches in selected patients
fondazionemichelangelo.org/it/notizie-e...
#FondazioneMichelangelo #CancerResearch

Analysis of the NeoTRIP trial showed that tumor-specific MHC-II expression is associated with improved response to neoadjuvant chemo-immunotherapy in early triple negative breast cancer
fondazionemichelangelo.org/news-update/...
#FondazioneMichelangelo #CancerResearch
@mauriziocallari.bsky.social

Camizestrant in association with abemaciclib, palbociclib or ribociclib shows a well-tolerated safety profile and encouraging clinical activity in heavily pretreated advanced breast cancer
fondazionebonadonna.org/en/camizestr...
#Oncology #CancerResearch
@mauriziocallari.bsky.social

Milan to host the Joint Conference 2025 on New Drugs and the Impact of AI in Oncology, organized by FGB with the Prada Group as supporting partner, Fondazione Michelangelo and @ESOncology .
Press Release fondazionebonadonna.org/area-press/
#FondazioneGianniBonadonna #FondazioneMichelangelo

“Online the Scientific Programme of the FGB-FM-ESO Joint International Conference 2025 “INNOVATION IN ONCOLOGY: New Drugs and the Impact of Artificial Intelligence”. Read more and register online at www.eso.net/en/what-we-d...

Fondazione Gianni Bonadonna, with #PradaGroup as supporting partner, announces the edition 2025 of the post-doctoral Fellowship Program in collaboration with the #ESOncology Applications open from June 3rd until July 20th.
#fondazionebonadonna #fellowship
fondazionebonadonna.org/en/a-new-edi...

Addition of tiragolumab might improve clinical activity of a combination with atezolizumab plus bevacizumab in unresectable, locally advanced or metastatic hepatocellular carcinoma
fondazionebonadonna.org/en/tiragolum...
#FondazioneBonadonna #BreastCancer #Oncology
@mauriziocallari.bsky.social

FGB, Prada Group, and European School of Oncology are pleased to announce the winners of Gianni Bonadonna Fellowship 24. For a 1-year period, 3 talented young doctors will pursue abroad their research projects in Oncology.
Press release fondazionebonadonna.org/wp-content/u...
#fondazionebonadonna